This evidence coupled with those obtained from preclinical studies in animal models showing that inhibition of NT/NTR pathway reduced atherosclerosis, plaque area, vascular inflammation and calcification11,26,43,44, suggest that elevated circulating NT levels not only are a biomarker of cardiovascular risk but may also contribute to the pathogenesis of cardiovascular organ damage. This evidence concerns the gene NTSR1 and atherosclerosis.